Miyuki Nakagawa
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial.
Journal: JHEP reports : innovation in hepatology
Published: June 13, 2025
Urinary thrombin as a non-invasive biomarker in renal diseases: a possible role in the detection of segmental sclerosis lesions in IgA nephropathy.
Journal: Clinical and experimental nephrology
Published: May 29, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes.
Journal: JHEP reports : innovation in hepatology
Published: April 26, 2025
Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination Immunotherapy.
Journal: Cancer medicine
Published: November 12, 2024
Evaluating two rechallenge strategies of immune checkpoint inhibitors: Durvalumab plus tremelimumab in advanced hepatocellular carcinoma.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: October 22, 2024
Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2024
Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy.
Journal: Liver cancer
Published: January 03, 2024
A Serine Protease Inhibitor, Camostat Mesilate, Suppresses Urinary Plasmin Activity and Alleviates Hypertension and Podocyte Injury in Dahl Salt-Sensitive Rats.
Journal: International journal of molecular sciences
Published: October 07, 2023
Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma.
Journal: Journal of gastroenterology
Published: August 24, 2023
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.
Journal: Drugs - real world outcomes
Published: June 19, 2023
Estimation of the effect of atezolizumab plus bevacizumab on pulmonary arterial hypertension using computed tomography in HCC patients.
Journal: Scientific reports
Published: March 24, 2023
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury.
Journal: Scientific reports
Published: January 08, 2023
Last Updated: 09/26/2026